VASP is an actin-regulatory protein that links signalling to remodelling of the cytoskeleton. We investigated the role of VASP during entry of herpes simplex viruses into epithelial MDCKII cells. As VASP functions are regulated by phosphorylations, the phosphorylation pattern was determined upon infection. Phosphorylated VASP decreased temporarily at 15 and 30 min after infection. The impact of phosphorylated VASP was addressed by overexpression of phosphomimetic VASP mutants. Our results revealed that phosphorylated VASP slightly reduced the number of infected cells. Expression studies with deletion mutants further indicated minor effects of VASP on infection efficiency, whereas RNA interference studies demonstrated that reduced VASP expression did not suppress infection. We conclude that VASP activities alone may contribute to herpes simplex virus infection to only a minor extent.
Herpes simplex virus type 1 (HSV-1) enters its human host via the epithelia of mucosa, skin or cornea, where primary infection is established. Cellular entry involves multiple steps and relies initially on the interaction of several viral glycoproteins with various cell-surface receptors (Heldwein & Krummenacher, 2008) . Depending on the cell line and the involved coreceptor, HSV-1 is internalized either by fusion of the viral envelope with the plasma membrane or by endocytic pathways (Nicola et al., 2003 Gianni et al., 2004; Nicola & Straus, 2004; Milne et al., 2005; Clement et al., 2006) . HSV-1 interaction with cell-surface receptors such as the cell-cell adhesion molecule nectin-1 leads to intracellular signalling that may trigger actin reorganization. The contribution of actin-based processes for initiation of HSV-1 infection is not well understood (Lyman & Enquist, 2009) . One major challenge for the virus is to overcome the actin cortex underneath the plasma membrane. Thus, the impact of actin dynamics on the entry pathway could vary depending on the cell type and mode of internalization. Recent infection studies in epithelial Madin-Darby canine kidney (MDCK) II cells indicate enhanced association of virus particles with cells forming actin protrusions such as lamellipodia (Hoppe et al., 2006) . Thus, we assume that lamellipodia-forming MDCKII cells represent preferred targets for HSV-1 infection, and hypothesize that actin dynamics during cell motility may contribute to the entry process.
VASP belongs to the Ena/VASP protein family and participates in a variety of actin-based processes such as cell migration, cell adhesion and the intracellular movement of the bacterial pathogen Listeria monocytogenes. The structure of VASP is tripartite, consisting of an EVH1 domain, a central proline-rich domain and a C-terminal EVH2 domain. The proline-rich region binds to SH3 domains and the actinbinding protein profilin, whereas the EVH2 domain supports F-actin binding and tetramerization. VASP localizes to sites of high actin dynamics, such as leading edges of lamellipodia and tips of filopodia, where it regulates filament elongation and branching (Krause et al., 2003; Kwiatkowski et al., 2003; Bear & Gertler, 2009 ). Human VASP harbours three phosphorylation sites (Ser157, Ser239 and Thr278) and is a substrate for serine/threonine kinases (Butt et al., 1994; Blume et al., 2007) . The multiple VASP phosphorylations modulate various cellular functions of the protein, e.g. phosphorylations within the EVH2 domain interfere with VASP binding to G-and F-actin, and negatively regulate VASP-mediated lamellipodia formation (Harbeck et al., 2000; Lindsay et al., 2007) . Thus, we addressed whether VASP functions play a role during HSV-1 entry.
Upon infection of MDCKII cells, we determined VASP expression levels at various early times post-infection (p.i.). Cells at low density, forming only small cell islets, were infected at a high infection rate as described previously (Schelhaas et al., 2003) . In protein extracts of subconfluent MDCKII cells, a polyclonal anti-VASP antibody (2010) (Bear et al., 2000) recognized a polypeptide doublet representing the non-phosphorylated VASP and the Ser157-phosphorylated form (pSer157-VASP) (Butt et al., 1994) (Fig. 1a) . The pSer239-and/or pThr278-VASP migrates at the same molecular mass as the non-phosphorylated VASP. The phosphorylation-status-specific antibody 5C6 detects only the slower-migrating pSer157-VASP (Smolenski et al., 2000; Blume et al., 2007) (Fig. 1b) . Consistent with previous studies, total protein extracts were analysed from cells that were collected with cell scrapers, as trypsin treatment increased the level of pSer157-VASP (Benz et al., 2008) . When cells were infected, pSer157-VASP levels decreased at 15 and 30 min p.i. followed by an increase at 60 and 120 min p.i., whilst the total amount of VASP was unchanged (Fig. 1a-c) . We conclude that infection changed VASP Ser157 phosphorylation. Additional changes in VASP Ser239 and/or Thr278 phosphorylations cannot be excluded.
As Ser157 phosphorylation controls subcellular VASP distribution in sparse endothelial cells (Benz et al., 2009), we performed immunofluorescence studies in MDCKII cells to analyse VASP localization during early infection. Staining with anti-VASP antibodies revealed no significant redistribution of VASP in the first 120 min of infection (data not shown). When subconfluent MDCKII cells were stained with anti-pSer157-VASP antibodies, the phosphorylated protein was enriched at cell-cell contacts and lamellipodia. In addition, a diffuse (probably unspecific) staining of the nucleus was observed (Fig. 1d) . Thus, HSV-1 infection did not change VASP localization markedly until 120 min p.i., although we cannot exclude minor differences in localization (Fig. 1d) .
We investigated the impact of VASP phosphorylations on the initiation of HSV-1 infection by overexpression of VASP phosphomimetic mutants prior to infection. The Ser157 or Ser239 residues were mutated either to an acidic residue or to alanine, to mimic a constitutively phos- phorylated or unphosphorylated protein, respectively (Blume et al., 2007; Benz et al., 2009) (Fig. 2) . MDCKII cells were transfected followed by HSV-1 infection and fixed at 2 h p.i. as described previously (Hoppe et al., 2006) . HSV-1-infected cells were visualized by staining with an antibody against the viral immediate-early protein ICP0 (Everett, 2000; Hoppe et al., 2006) . In cells that overexpressed phosphorylation-defective mutants AST or SAT, we observed ICP0 expression, as in control cells that expressed green fluorescent protein (GFP) only (Fig. 2a, b) . When the constitutively phosphorylated mutants DST or SDT were expressed prior to infection, the number of infected cells was reduced to 59 and 71 %, respectively, compared with 89 and 84 % of AST-or SAT-expressing cells (Fig. 2a, b) . The significant reduction in the number of infected cells was similar when wild-type (wt) VASP was overexpressed, suggesting that phosphorylation of Ser157 and/or Ser239 in wt VASP had reducing effects similar to those of the constitutively phosphorylated mutants (Fig.  2a, b) . The effect on infection of mutant VASP expression was further confirmed by flow-cytometric analyses, which selected mutant-expressing cells by use of bicistronically expressed GFP (Blume et al., 2007) (data not shown). In summary, our results indicate a reducing effect of pSer157-and/or pSer239-VASP on the number of infected MDCKII cells at early times p.i., whilst phosphorylation-defective Ser157 and Ser239 sites did not interfere with HSV-1 infectivity.
The potential role of VASP during HSV-1 infection was investigated further by overexpression of VASP deletion mutants prior to infection. We analysed the effect of EVH2 deletion mutants for initiation of infection, as the EVH2 domain participates in regulating actin assembly (Grosse et al., 2003) . VASP mutants with deletion of the complete EVH2 domain (EVH1-PP) or of the B-subdomain within the EVH2 domain (DB) interfere with F-actin assembly (Grosse et al., 2003) . The B-subdomain mediates F-actin binding in vitro (Bachmann et al., 1999) . When mutants EVH1-PP and DB were overexpressed in MDCKII cells 24 h prior to HSV-1 infection, the number of infected cells was reduced to 44 and 53 %, respectively, compared with 92 % of cells expressing GFP only (Fig. 2c, d) . A similar reducing effect was observed in wt VASP-expressing cells, suggesting a dominant-negative phenotype (Fig. 2c) .
Immunofluorescence studies of mutant-expressing cells visualized viral ICP0 expression in the nucleus, indicating an early time point after infection that was followed by cytoplasmic ICP0 localization later during infection (Hoppe et al., 2006) (Fig. 2e) . All deletion mutants and wt VASP-expressing cells showed a nuclear ICP0 expression pattern that was similar to that seen in untransfected cells, indicating that progression of early infection is comparable in each infected cell (Fig. 2e) . The number of infected cells, however, decreased upon expression of the VASP mutants EVH1-PP and DB, as well as of the wt protein. Whilst the mutants EVH1-PP and DB interfere with F-actin assembly, expression of wt VASP increases cellular F-actin, which might explain the reducing effects of all three constructs on infection (Grosse et al., 2003; Benz et al., 2009 ). When we investigated the effect on Factin in MDCKII cells expressing wt VASP or the EVH2 domain, we found both proteins accumulating at the cell periphery and enhanced association with F-actin bundles (data not shown). In contrast, the EVH1-PP protein that lacks the EVH2 domain was localized diffusely in the cytoplasm and nucleus (Fig. 2e) . Therefore, we assume that interference with VASP-regulated F-actin assembly blocks initiation of HSV-1 infection at least in some cells.
In addition to overexpression of VASP mutants, we silenced VASP expression by RNA interference to analyse further the impact of VASP during early HSV-1 infection in MDCKII cells. Subconfluent cells were transfected with either specific VASP or control small interfering RNAs (siRNAs) using HiPerFect reagent (Qiagen) as described previously (Petermann et al., 2009) . At 48 h post-transfection, efficient reduction was observed by Western blot analyses with anti-VASP antibodies (Fig. 3c) . When F-actin was stained upon VASP silencing, there was no detectable change in F-actin structures compared with cells treated with control siRNAs (Fig. 3a) . Upon infection of transfected cells, ICP0 expression was found mainly in the cytoplasm, which indicated very efficient infection both in the absence and in the presence of VASP (Fig. 3b) . Quantification revealed even a slight increase in the number of infected cells when VASP expression was reduced (Fig. 3d) . A possible explanation is that reduced VASP expression affected cell-cell contacts that allowed easier access of HSV-1 to the plasma membrane. Thus, we conclude that reduced VASP expression did not interfere with HSV-1 infectivity. The lack of actin remodelling in cells with reduced VASP expression is in line with observations in VASP-deficient fibroblasts and endothelial cells that showed minor effects on actin-based processes (Hauser et al., 1999; Bear et al., 2000) .
Recent studies suggest that HSV-1 infection of keratinocytes does not depend on Rac1/Cdc42 signalling; however, constitutively active Rac1 and Cdc42 have the potential to interfere with HSV-1 infectivity in keratinocytes as well as in MDCKII cells (Hoppe et al., 2006; Petermann et al., 2009) . In epithelial cells expressing constitutively active Rac1, an increase in VASP expression was observed in addition to upregulation of vinculin and profilin (Quinlan, 2004) . Thus, we addressed whether the inhibitory effect of active Rac1 on HSV-1 infectivity is mediated by VASP expression. When active Rac1 was expressed in MDCKII cells in which VASP expression was reduced, infection was still inhibited, suggesting that VASP did not trigger the inhibitory effect of active Rac1 (data not shown). However, it is interesting to note that, upon infection, reduced VASP phosphorylation coincided with an increase in Rac1 and Cdc42 activities (Hoppe et al., 2006; Petermann et al., 2009 ). Transfection was performed by electroporation (Amaxa) as described previously (Hoppe et al., 2006) . At 2 h p.i., cells were fixed and infected cells were visualized by staining with rabbit anti-ICP0 antibodies (diluted 1 : 500) as described previously (Hoppe et al., 2006) . The number of ICP0-expressing cells per mutant-expressing cell was determined. Grosse et al. (2003) ] that carry a Myc tag at the N terminus. Wt VASP includes the domains EVH1 and PRO and the A, B, D and C subdomains within the EVH2 domain. Localization of the three phosphorylation sites Ser157, Ser239 and Thr278 is indicated. Construct EVH1-PP (aa 1-225) lacks the EVH2 domain; in construct DB, subdomain B (aa 258-277) is deleted and replaced by three alanine codons; and construct EVH2 includes only the EVH2 domain (aa 225-380). (e) Costaining with rabbit anti-ICP0 antibodies (red) and mouse anti-Myc (green) was visualized by Alexa Fluor 555-conjugated anti-rabbit (Molecular Probes) and Alexa Fluor 488-conjugated anti-mouse (Molecular Probes) antibodies, respectively. Single stainings and merged images of confocal projections are shown. Bar, 50 mm.
In summary, our studies in MDCKII cells demonstrate temporary changes in VASP phosphorylation status upon HSV-1 infection. Studies on the functional significance suggest that VASP phosphorylation at Ser157 and/or Ser239 can reduce infection efficiency. Thus, decreased pSer157-VASP levels at 15 and 30 min p.i. may promote initial infection. Overexpression of VASP deletion mutants that can lead to disturbed VASP-regulated F-actin assembly interfered with infection, whilst reduced VASP expression had no effect on the initiation of infection in MDCKII cells. 
